{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:18:08Z","timestamp":1791569888417,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12969-019-0325-6","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:03:43Z","timestamp":1559055823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial"],"prefix":"10.1186","volume":"17","author":[{"given":"Himanshu P.","family":"Upadhyaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley M.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Alaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"issue":"12","key":"325_CR1","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1016\/j.pain.2011.07.016","volume":"152","author":"S King","year":"2011","unstructured":"King S, Chambers CT, Huguet A, MacNevin RC, McGrath PJ, Parker L, et al. The epidemiology of chronic pain in children and adolescents revisited: a systematic review. Pain. 2011;152(12):2729\u201338.","journal-title":"Pain."},{"issue":"1","key":"325_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0304-3959(00)00269-4","volume":"87","author":"CW Perquin","year":"2000","unstructured":"Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, Bohnen AM, van Suijlekom-Smit LW, Passchier J, et al. Pain in children and adolescents: a common experience. Pain. 2000;87(1):51\u20138.","journal-title":"Pain."},{"issue":"2","key":"325_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrrheum.2013.177","volume":"10","author":"S Kashikar-Zuck","year":"2014","unstructured":"Kashikar-Zuck S, Ting TV. Juvenile fibromyalgia: current status of research and future developments. Nat Rev Rheumatol. 2014;10(2):89\u201396.","journal-title":"Nat Rev Rheumatol"},{"key":"325_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.15517\/ap.v30i121.24579","volume":"30","author":"L G\u00f3mez-de-Regil","year":"2016","unstructured":"G\u00f3mez-de-Regil L, \u00c1lvarez-Nemegyei J. Open access scientific evidence of cognitive behavioral therapy for patients with fibromyalgia. Actualidades en Psicolog\u00eda. 2016;30:91\u2013102.","journal-title":"Actualidades en Psicolog\u00eda"},{"issue":"3","key":"325_CR5","first-page":"415","volume":"18","author":"A Gedalia","year":"2000","unstructured":"Gedalia A, Garcia CO, Molina JF, Bradford NJ, Espinoza LR. Fibromyalgia syndrome: experience in a pediatric rheumatology clinic. Clin Exp Rheumatol. 2000;18(3):415\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"325_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1477-7525-5-9","volume":"5","author":"JW Varni","year":"2007","unstructured":"Varni JW, Burwinkle TM, Limbers CA, Szer IS. The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains. Health Qual Life Outcomes. 2007;5:9.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"325_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/art.1780280205","volume":"28","author":"MB Yunus","year":"1985","unstructured":"Yunus MB, Masi AT. Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls. Arthritis Rheum. 1985;28(2):138\u201345.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"325_CR8","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. 1994;23(2):129\u201338.","journal-title":"Ann Acad Med Singap"},{"issue":"9","key":"325_CR9","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/art.20485","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50(9):2974\u201384.","journal-title":"Arthritis Rheum"},{"issue":"1\u20133","key":"325_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","volume":"119","author":"LM Arnold","year":"2005","unstructured":"Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119(1\u20133):5\u201315.","journal-title":"Pain."},{"issue":"3","key":"325_CR11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"IJ Russell","year":"2008","unstructured":"Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008;136(3):432\u201344.","journal-title":"Pain."},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJGM.S3979","volume":"1","author":"AS Chappell","year":"2008","unstructured":"Chappell AS, Bradley LA, Wiltse C, Detke MJ, D'Souza DN, Spaeth M. A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia. Int J Gen Med. 2008;1:91\u2013102.","journal-title":"Int J Gen Med"},{"issue":"9","key":"325_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/AJP.0b013e3182510295","volume":"28","author":"LM Arnold","year":"2012","unstructured":"Arnold LM, Zhang S, Pangallo BA. Efficacy and safety of duloxetine 30 mg\/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study. Clin J Pain. 2012;28(9):775\u201381.","journal-title":"Clin J Pain"},{"issue":"1","key":"325_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12969-016-0106-4","volume":"14","author":"LM Arnold","year":"2016","unstructured":"Arnold LM, Schikler KN, Bateman L, Khan T, Pauer L, Bhadra-Brown P, et al. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study. Pediatr Rheumatol Online J. 2016;14(1):46.","journal-title":"Pediatr Rheumatol Online J."},{"key":"325_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12969-015-0025-9","volume":"13","author":"LM Arnold","year":"2015","unstructured":"Arnold LM, Bateman L, Palmer RH, Lin Y. Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program. Pediatr Rheumatol Online J. 2015;13:27.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"325_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaac.2015.01.008","volume":"54","author":"JR Strawn","year":"2015","unstructured":"Strawn JR, Prakash A, Zhang Q, Pangallo BA, Stroud CE, Cai N, et al. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2015;54(4):283\u201393.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"325_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/cap.2014.0076","volume":"25","author":"GJ Emslie","year":"2015","unstructured":"Emslie GJ, Wells TG, Prakash A, Zhang Q, Pangallo BA, Bangs ME, et al. Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol. 2015;25(4):293\u2013305.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"9","key":"325_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s10067-009-1203-2","volume":"28","author":"EH Choy","year":"2009","unstructured":"Choy EH, Mease PJ, Kajdasz DK, Wohlreich MM, Crits-Christoph P, Walker DJ, et al. Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials. Clin Rheumatol. 2009;28(9):1035\u201344.","journal-title":"Clin Rheumatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-019-0325-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:19:00Z","timestamp":1590535140000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-019-0325-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1186\/s12969-019-0325-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"6 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study protocols and informed consent forms were approved by an Institutional Review Board at each site. The parent\/legal representative signed the informed consent form, and the patient signed the assent document (if applicable) prior to initiation of any study-related procedures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Himanshu P Upadhyaya, MBBS, MS, MBA, Karla Alaka, MMSc are full-time employees of Eli Lilly and Company and\/or one of its subsidiaries, and may hold company stocks; Lesley Arnold, MD, is a full-time employee of University of Cincinnati College of Medicine; Meihua Qiao, PhD, and David Williams, MS, are full-time employees of Syneos Health; Renata Mehta, MSc, is a full-time employee of Hoffman-La Roche.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"27"}}